Dreams can be powerful, but when combined with action, they become transformative. Sankalp, a visionary with an unwavering belief in the power of persistence, is the perfect blend of dreamer and doer.

Many women in India seek antenatal care late, with 1 in 6 starting after 18 weeks. Sankalp Labs has now secured registration to offer fetal genetic testing for thalassemia and sickle cell diseases, reducing wait times from weeks to just 3 days.

Sankalp Labs is transforming infection diagnostics for bone marrow transplant patients with rapid PCR tests targeting antimicrobial resistance (AMR). These tests detect pathogens within hours, enabling faster, targeted treatments and reducing unnecessary antibiotic use.

Blood Donation Drives (Nov-Dec 2024)

Jasper from Zambia, diagnosed with Sickle Cell Disease at age 1, faced endless hospital visits until a perfect match was found with his sister, Mercu, through DKMS, Germany. In March 2024, he received a life-changing bone marrow transplant at our Bangalore center.

A Tanzanian medical team visited Bangalore for 15 days to learn about Bone Marrow Transplant (BMT) setup and management at BMJH. They gained insights on BMT room setup, transplant protocols, and post-transplant care.

Sankalp is proud to announce the strengthening of its Clinical Research Team, marking a significant milestone in its ongoing journey of scientific discovery. What began with a simple curiosity-driven approach has evolved into a cutting-edge initiative that combines advanced medicine, information technology, and diagnostics.

In November 2024, Thalassemia management teams from 21 centers attended a two-day training in Bangalore and Ahmedabad. The event focused on improving patient care, with a heartwarming greeting from patients in remission. Teams exchanged best practices, tackled high-risk cases, and worked on action plans for better outcomes. Dr.

In the last quarter of 2024, thalassemia prevention coordinators from across India took part in a series of valuable training sessions. In Maharashtra, the focus was on building confidence, with role-playing exercises that helped coordinators improve their counseling skills.

Twelve years ago, a dream was born to save lives by freezing Bombay blood group units, extending their shelf life from 42 days to 10 years. Despite countless challenges and setbacks, the team at Sankalp Blood Center never gave up. In November 2023, their relentless dedication resulted in the first successful transfusion of a frozen red blood cell.

This heartwarming achievement ensures that patients with rare blood types now have hope, marking a life-saving breakthrough driven by passion, perseverance, and the commitment to making a difference.